Treatment of Advanced Non-Small Cell Luna Cancer in 2018

被引：88
作者：
Doroshow, Deborah B. [1 ]
Herbst, Roy S. [1 ]
机构：
[1] Yale Canc Ctr, 333 Cedar St,POB 208028, New Haven, CT 06520 USA
来源：
JAMA ONCOLOGY | 2018年 / 4卷 / 04期
关键词：
PHASE-III; PEMBROLIZUMAB; CHEMOTHERAPY; OSIMERTINIB; CARBOPLATIN;
D O I：
10.1001/jamaoncol.2017.5190
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：569 / 570
页数：2
相关论文
共 50 条
  • [21] The emerging role of ALK inhibitors in the treatment of advanced non-small cell lung cancer
    Galetta, Domenico
    Rossi, Antonio
    Pisconti, Salvatore
    Colucci, Giuseppe
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2012, 16 : S45 - S54
  • [22] Gemcitabine and carboplatin in combination for the treatment of advanced, metastatic, non-small cell lung cancer
    Nagel, Sylke
    Califano, Raffaele
    Thatcher, Nicholas
    Blackhall, Fiona
    EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (18) : 3265 - 3275
  • [23] Treatment of Advanced Non-Small Cell Lung Cancer with RET Fusions: Reality and Hopes
    Rocco, Danilo
    Sapio, Luigi
    Della Gravara, Luigi
    Naviglio, Silvio
    Gridelli, Cesare
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (03)
  • [24] Microwave Ablation in Combination with Chemotherapy for the Treatment of Advanced Non-Small Cell Lung Cancer
    Wei, Zhigang
    Ye, Xin
    Yang, Xia
    Zheng, Aimin
    Huang, Guanghui
    Li, Wenhong
    Ni, Xiang
    Wang, Jiao
    Han, Xiaoying
    CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2015, 38 (01) : 135 - 142
  • [25] Sequential treatment in advanced non-small cell lung cancer harboring EGFR mutations
    Hsu, Ping-Chih
    Chang, John Wen-Cheng
    Chang, Ching-Fu
    Huang, Chen-Yang
    Yang, Cheng-Ta
    Kuo, Chih-Hsi Scott
    Fang, Yueh-Fu
    Wu, Chiao-En
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2022, 16
  • [26] Controversies in the management of advanced non-small cell lung cancer: maintenance therapy
    Dediu, M.
    JOURNAL OF BUON, 2011, 16 (03): : 431 - 433
  • [27] The role of pembrolizumab in the treatment of advanced non-small cell lung cancer
    Santabarbara, Giuseppe
    Maione, Paolo
    Rossi, Antonio
    Palazzolo, Giovanni
    Gridelli, Cesare
    ANNALS OF TRANSLATIONAL MEDICINE, 2016, 4 (11)
  • [28] Gefitinib or Erlotinib in the Treatment of Advanced Non-small Cell Lung Cancer
    Shao, Yu-Yun
    Lin, Chia-Chi
    Yang, Chih-Hsin
    DISCOVERY MEDICINE, 2010, 9 (49) : 538 - 545
  • [29] Combination bezafibrate and nivolumab treatment of patients with advanced non-small cell lung cancer
    Tanaka, Kentaro
    Chamoto, Kenji
    Saeki, Sho
    Hatae, Ryusuke
    Ikematsu, Yuki
    Sakai, Kazuko
    Ando, Nobuhisa
    Sonomura, Kazuhiro
    Kojima, Shinsuke
    Taketsuna, Masanori
    Kim, Young Hak
    Yoshida, Hironori
    Ozasa, Hiroaki
    Sakamori, Yuichi
    Hirano, Tomoko
    Matsuda, Fumihiko
    Hirai, Toyohiro
    Nishio, Kazuto
    Sakagami, Takuro
    Fukushima, Masanori
    Nakanishi, Yoichi
    Honjo, Tasuku
    Okamoto, Isamu
    SCIENCE TRANSLATIONAL MEDICINE, 2022, 14 (675)
  • [30] Gemcitabine and carboplatin in the treatment of locally advanced and metastatic non-small cell lung cancer
    Leow, CH
    Liam, CK
    RESPIROLOGY, 2005, 10 (05) : 629 - 635
12345